About

Company

Carlsmed is leveraging AI and predictive analytics to utilize prior outcomes data for personalizing the treatment of complex adult spinal deformities.

The company’s proprietary CorraTM platform makes surgical plans and devices tailored to the precise medical situation of every individual patient. This is transforming healthcare by finally giving spine surgeons the tools to obtain better results at a lower cost of treatment while helping adults regain their active lifestyles.

CARLSMED is currently incubating at Southern California’s most successful technology startup incubator EvoNexus and maintains offices in San Diego and Seattle.

EXECUTIVE MANAGEMENT

Our team is dedicated to improving outcomes in complex spine surgery.

We have over 100 years of combined clinical and industry leadership experience with an exceptional record of delivering on our business goals.

Mike Cordonnier

Chief Executive Officer

Sharon Schulzki

Chief Operating Officer

Niall Casey, Esq.

Chief Technology Officer

Alexander Arrow, M.D., C.F.A.

Chief Financial Officer

Justin Esterberg, M.D.

Chief Medical Officer

Mike is an accomplished MedTech industry leader with a track record of executing on commercial launch objectives. Mike has held various leadership roles for large MedTech companies NuVasive, Zimmer Biomet, and Orchid Orthopedics as well as startups Ellipse Technologies and X-Spine Systems. Most recently, Mike led the commercialization of the PRECICE deformity correction technology for Ellipse Technologies that was subsequently acquired by NuVasive and spun out as NuVasive Specialized Orthopedics. Prior to Ellipse, Mike led the development and successful launch of the patient specific digital dentistry business at Zimmer Biomet. Mike has a B.S. in Mechanical Engineering from the University of Dayton.

Ms. Schulzki is a seasoned industry executive and has been Instrumental in driving multiple high return exit events in orthopedics and spine, including transactions with Synthes, JNJ and Medtronic.  She also built three highly successful businesses in the spine and CMF spaces, and has held VP or C-Level positions with Stryker, Synthes, JNJ and Macropore.  Most recently, Sharon was with Tissue Regeneration Systems Inc, a University of Michigan spin-out company with two core technology platforms. The TRS 3D printed resorbable polymer technology was acquired by Depuy Synthes in 2017 and the nanostructured calcium phosphate coating technology was exclusively licensed to Medtronic Spine and Biologics in 2019. Sharon has a B.S. in Medical Technology from Loyola University Maryland.

Niall Casey is a spine industry veteran and has made major contributions to the development and IP protection of spine surgery devices over the past twenty years. He is a prolific inventor with more than 20 patents and has held key technical roles at market leaders JNJ DePuy Synthes and NuVasive. He has also practiced patent law at MIT and in private practice. Most recently, Niall was with Ellipse Technologies, where he led the development of the MAGEC spine deformity system. Niall has a B.S. and M.S. in Biomedical Engineering from Case Western Reserve University and a law degree from Suffolk University.

Dr. Arrow is a MedTech executive with a 23-year record of C-suite and financial leadership roles. The CFO of Protagenic Therapeutics, Inc. (PTIX) and the CEO of Zelegent, Inc., he was previously President and COO and a Director of Biolase, Inc. (BIOL), and he chaired the Audit and Compensation committees of the Board. Dr. Arrow has also been the CMO of Stanford-affiliated neuroscience company Circuit Therapeutics, Inc. He spent five years as CFO of cardiovascular device manufacturer Arstasis, Inc.  Before MedTech operating roles, Dr. Arrow spent nine years in equity research at three Wall Street firms, most recently as head of MedTech research at Lazard, Ltd. He also spent two years as CFO of the Patent & License Exchange, Inc. He has an MD from Harvard Medical School and a BA in Biophysics, magna cum laude, from Cornell University. He serves as an independent director on the Boards of wound care company Medcura, Inc. and Special Purpose Acquisition Company 8i Enterprises (JFK).

Dr. Esterberg is a board-certified orthopaedic surgeon specializing in spinal disorders with more than 15 years clinical experience. His practice at Swedish Medical Center is focused on minimally invasive and complex spine surgery where he treats adults with complex spine disorders. Dr. Esterberg is passionate about medical technology and has multiple patents related to surgical workflow, navigation and robotics. He co-founded Precisive Surgical, which was acquired by Carlsmed in 2019. Dr. Esterberg completed his orthopedic surgery residency at the University of Minnesota and his complex spine surgery fellowship at the prestigious Leatherman Spine Institute in Louisville.

Mike Cordonnier

Chief Executive Officer

Mike is an accomplished MedTech industry leader with a track record of executing on commercial launch objectives. Mike has held various leadership roles for large MedTech companies NuVasive, Zimmer Biomet, and Orchid Orthopedics as well as startups Ellipse Technologies and X-Spine Systems. Most recently, Mike led the commercialization of the PRECICE deformity correction technology for Ellipse Technologies that was subsequently acquired by NuVasive and spun out as NuVasive Specialized Orthopedics. Prior to Ellipse, Mike led the development and successful launch of the patient specific digital dentistry business at Zimmer Biomet. Mike has a B.S. in Mechanical Engineering from the University of Dayton.

Sharon Schulzki

Chief Operating Officer

Ms. Schulzki is a seasoned industry executive and has been Instrumental in driving multiple high return exit events in orthopedics and spine, including transactions with Synthes, JNJ and Medtronic.  She also built three highly successful businesses in the spine and CMF spaces, and has held VP or C-Level positions with Stryker, Synthes, JNJ and Macropore.  Most recently, Sharon was with Tissue Regeneration Systems Inc, a University of Michigan spin-out company with two core technology platforms. The TRS 3D printed resorbable polymer technology was acquired by Depuy Synthes in 2017 and the nanostructured calcium phosphate coating technology was exclusively licensed to Medtronic Spine and Biologics in 2019. Sharon has a B.S. in Medical Technology from Loyola University Maryland.

Niall Casey, Esq.

Chief Technology Officer

Niall Casey is a spine industry veteran and has made major contributions to the development and IP protection of spine surgery devices over the past twenty years. He is a prolific inventor with more than 20 patents and has held key technical roles at market leaders JNJ DePuy Synthes and NuVasive. He has also practiced patent law at MIT and in private practice. Most recently, Niall was with Ellipse Technologies, where he led the development of the MAGEC spine deformity system. Niall has a B.S. and M.S. in Biomedical Engineering from Case Western Reserve University and a law degree from Suffolk University.

Alexander Arrow, M.D., C.F.A.

Chief Financial Officer

Dr. Arrow is a MedTech executive with a 23-year record of C-suite and financial leadership roles. The CFO of Protagenic Therapeutics, Inc. (PTIX) and the CEO of Zelegent, Inc., he was previously President and COO and a Director of Biolase, Inc. (BIOL), and he chaired the Audit and Compensation committees of the Board. Dr. Arrow has also been the CMO of Stanford-affiliated neuroscience company Circuit Therapeutics, Inc. He spent five years as CFO of cardiovascular device manufacturer Arstasis, Inc.  Before MedTech operating roles, Dr. Arrow spent nine years in equity research at three Wall Street firms, most recently as head of MedTech research at Lazard, Ltd. He also spent two years as CFO of the Patent & License Exchange, Inc. He has an MD from Harvard Medical School and a BA in Biophysics, magna cum laude, from Cornell University. He serves as an independent director on the Boards of wound care company Medcura, Inc. and Special Purpose Acquisition Company 8i Enterprises (JFK).

Justin Esterberg, M.D.

Chief Medical Officer

Dr. Esterberg is a board-certified orthopaedic surgeon specializing in spinal disorders with more than 15 years clinical experience. His practice at Swedish Medical Center is focused on minimally invasive and complex spine surgery where he treats adults with complex spine disorders. Dr. Esterberg is passionate about medical technology and has multiple patents related to surgical workflow, navigation and robotics. He co-founded Precisive Surgical, which was acquired by Carlsmed in 2019. Dr. Esterberg completed his orthopedic surgery residency at the University of Minnesota and his complex spine surgery fellowship at the prestigious Leatherman Spine Institute in Louisville.

SURGEON ADVISORY BOARD

Our decades of collaboration with the world’s leading spine surgeons has given us the inside track.

We continue to listen to and learn from these experts as we drive transformative change in complex spine surgery.



Chris Ames, M.D.

Shay Bess, M.D.


Gregory Mundis Jr., M.D.

Justin Smith, M.D.

Board Of Directors

Mike Cordonnier

Chairman

Niall Casey, Esq.

Director

Justin Esterberg, M.D.

Director

Jeffrey Roh, M.D.

Director
© 2020 CARLSMED, Inc.
closelinkedin-squarebars